Loading clinical trials...
Loading clinical trials...
Chronic lymphocytic leukemia (CLL), a form of Non-Hodgkin's Lymphoma, is the most common type of leukemia in adults, affecting approximately 3,800 people in the UK each year. This study will evaluate ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT07221500 · Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
NCT05672251 · Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Grade 3b Follicular Lymphoma, and more
NCT06846671 · CLL, Chronic Lymphocytic Leukemia
NCT07218341 · Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
NCT05294731 · B-cell Malignancy, Non-Hodgkin Lymphoma, and more
Barts Health NHS Trust /ID# 252717
London, London, City of
Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 252720
Norwich, Norfolk
Nottingham City Hospital /ID# 252716
Nottingham, Nottinghamshire
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions